Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - SELLAS Life Sciences Group, Inc. | b78743e10vk.htm |
| EX-32.1 - EX-32.1 - SELLAS Life Sciences Group, Inc. | b78743exv32w1.htm |
| EX-31.2 - EX-31.2 - SELLAS Life Sciences Group, Inc. | b78743exv31w2.htm |
| EX-31.1 - EX-31.1 - SELLAS Life Sciences Group, Inc. | b78743exv31w1.htm |
| EX-10.28 - EX-10.28 - SELLAS Life Sciences Group, Inc. | b78743exv10w28.htm |
| EX-10.27 - EX-10.27 - SELLAS Life Sciences Group, Inc. | b78743exv10w27.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
RXi Pharmaceuticals Corporation
Worcester, MA
Worcester, MA
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3
(No. 333-158968) and Form S-8 (Nos. 333-151154 and 333-1583847) of RXi Pharmaceuticals Corporation
of our report dated March 31, 2010, relating to the financial statements which appear in this Form
10-K.
/s/ BDO Seidman, LLP
Boston, MA
Boston, MA
March 31, 2010